Biotechnology Sector Analysis

Over the last 15 years I have profiled the personalities of over 1,000 people in 100 biotechnology organisations. The personality profile data can be analysed to identify themes amongst PhD students, postdoctoral researchers, early, mid, and later career people in different roles and benchmark teams across the sector. The BIA Blog below summarises some of the findings and in addition we assessed the findings from working with the Resilience Centre of Excellence leadership Accelerator cohort. They were:

Supporting Early-Career Talent to Thrive

Analysis of 170 participants in the RESILIENCE Leadership Accelerator highlights a cohort with strong interpersonal skills, a collaborative approach and significant potential to contribute to innovation across the life sciences sector.

Participants typically work in a logical, systematic and evidence-based way, building effective relationships and making considered decisions that balance team and organisational priorities. These qualities are particularly valuable within scientific and highly regulated environments.

The findings also identify opportunities for development. Greater confidence, resilience, adaptability and emotional regulation can help participants manage workplace pressure, make decisions more quickly and engage more confidently with change and innovation. Many are naturally quiet and risk-aware, with latent intrapreneurial potential that can be unlocked when they understand their role, feel supported and are given permission to contribute.

Effective leaders of early-career teams should therefore adopt a supportive, nurturing and analytical style — providing clear objectives, realistic timescales and a stable environment that builds confidence and encourages engagement with change.

Developing these capabilities has benefits beyond the individual. It can strengthen collaboration and innovation across academia, industry and the wider life sciences community, helping the UK translate its research strengths into the discovery, development and manufacture of medicines.

Although a while back now the visual below was based on the input from 150 individuals. They were drawn live at the 20th Annual bioProcessUK Conference, run by the BioIndustry Association.

The output from 300 contributions from 150 people